Company / Income Tax
Gilead Sciences Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$1.3B
FY2025
5-year range
-$204.0M / $2.1B
FY2021-FY2025
Trend
+509.5%
vs FY2024
Sector context
#6 of 204
Health Care
What the data says
Income Tax changed +509% YoY in FY2025, a notable deviation from the 9-year average annual change of +145%.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of -4.0%. Top quartile in the Health Care sector.
Improved from $2.1B to $1.3B over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -6.6%
- 5-Year CAGR
- -4.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 204This company $1.3B Sector average $118.7M
▼
+983.1% above sector average
Key checks
Key Insights
- 5-year CAGR of -4.0%, indicating a declining trend.
- In FY2025, income tax increased 509.5% year-over-year.
- Ranks #6 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2019.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | +509.5% |
| FY2024 | $211.0M | -89.8% |
| FY2023 | $2.1B | +31.5% |
| FY2022 | $1.6B | +874.5% |
| FY2021 | -$204.0M | -112.9% |
| FY2020 | $1.6B | -82.2% |
| FY2019 | $8.9B | +146.2% |
| FY2018 | $3.6B | +1.6% |
| FY2017 | $3.6B | +27.0% |
| FY2016 | $2.8B | -21.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026